Kenota 1 CWS Method Comparison Validation Study

CompletedOBSERVATIONAL
Enrollment

411

Participants

Timeline

Start Date

January 27, 2023

Primary Completion Date

April 7, 2023

Study Completion Date

April 7, 2023

Conditions
AllergyImmunoglobulin E-Mediated Allergic Disorder
Interventions
DIAGNOSTIC_TEST

Total Immunoglobulin E, Obtained From Fingerstick Sample

The Kenota 1 System is intended to be a specialized tool in a professional allergist setting. It will help streamline the patient testing process by bringing quantitative, minimally invasive fingerstick IgE blood testing to the allergy clinic.

Trial Locations (3)

23456

Children's Specialty Group, Virginia Beach

27514

Allergy Partners of Chapel Hill, Chapel Hill

55116

St. Paul Allergy & Asthma, Saint Paul

All Listed Sponsors
lead

Kenota Inc.

INDUSTRY